Cosmeceutical company SkinCeuticals has released a new serum that aims to address visible discolouration in skin to deliver a brighter, more even tone.
The Discoloration Defense Serum is formulated to address pigmentation triggered by inflammatory processes in the skin such as melasma triggered by hormonal changes and acne-scarring, according to SkinCeuticals.
The product contains 1.8% tranexamic acid, 5% niacinamide, and 5% 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES).
A 12-week single-center, clinical study looked at 63 females, aged 26-60, with Fitzpatrick I-IV and mild to moderate facial pigmentation, including melasma, post-inflammatory hyperpigmentation and hyperpigmentation who applied Discoloration Defense Serum to the face twice a day in conjunction with a sunscreen.
Patients demonstrated a statistically significant reduction in the appearance of post-inflammatory discolouration and uneven skin tone, including a 41% average reduction in the appearance of melasma, according to the company.
“Discoloration Defense Serum is an innovative daily treatment clinically proven to reduce the appearance of visible discolouration, including hard-to-treat forms such as stubborn brown patches and post-inflammatory discolouration, in just 14 days,” Dr Alexis Granite, a consultant dermatologist practising at the Cadogan Clinic and Mallucci London, said. She added, “In clinic, I use the serum as a complement to professional discolouration treatments, such as chemical peels. I also recommend Discoloration Defense Serum for daily home use by patients whom wish to break the pigmentation cycle and take a long-term approach to the care of their skin to provide a clearer, more revitalised complexion.”